Zion Market Research has published a new report titled “Global Platelet Aggregation Devices Market by Product (Systems, Reagents and Consumables & Accessories), by Application (Clinical and Research), by End-User (Standalone Hospitals, Diagnostic Laboratories, Research & Academic Institutes and Other End-Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022.” According to the report, the global platelet aggregation devices market accounted for USD 216.3 million in 2016 and is expected to reach USD 427.0 million by 2022, growing at a CAGR of around 20.1% between 2017 and 2022.
Platelet aggregation devices market is expected to witness a significant growth owing to rising incidence of diseases such as dengue and malaria in Asia and a significant patient population undergoing surgeries across the world is expected to fuel the global platelet aggregation devices in coming five years. Platelets are types of blood cells which are also known as blood clot cells whose function is to stop bleeding by clumping and clotting blood vessel injuries. Without platelets, someone could bleed to death. Abnormal platelet aggregation leads to life-threatening disorders such as Glanzmann Thrombasthenia. Platelet aggregation disorder is hereditary or acquired. A platelet aggregation test checks how well the platelets clump together. Various medical devices are used to examine the platelet aggregation disorder. As per the centers for disease control and prevention (USA Gov.) hemophilia affects 1 in 5,000 male births and about 400 babies are born with hemophilia each year in U.S. In addition, age has a significant effect on platelet aggregation behavior so the geriatric population across the globe is expected to be one of the driving factors of the demand for platelet aggregation devices within the forecast period.
With the increasing number of platelet aggregation disorders, the demand for the platelet aggregation devices is increasing rapidly. In addition, major growth drivers for the platelet aggregation devices market are increasing the incidence of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometer within the forecast period. Furthermore, the demand for platelet aggregation devices is also expected to fuel by some other factors like increasing number of surgeries, increasing awareness and development of new technology in platelet aggregation devices market. In addition, increasing the incidence of disorders like; thrombocythemia; an abnormal increase in the number of platelets and thrombocytopenia; a decrease in the number of platelets) is expected to boost the demand for platelet function test market during the forecast period. However, the high cost of purchase, the dearth of well trained & skilled professionals and unfavorable healthcare reforms in the U.S. are expected to decelerate the growth in this market in coming five years. In spite of these restraints, research and development in the platelet devices market are expected to be an opportunity for this market in the forecast period.
On the basis of product, the global platelet aggregation devices market is categorized into; systems, reagents and consumables & accessories. In this segment, platelet aggregation systems dominated the market by accounting for the largest share of the global market in 2016. Major growth driver for the demand of systems includes continuous technological advancements in the field of sensors and detectors coupled with growing adoption & market preference for automated instruments among diagnostic laboratories.
On the basis of application, the platelet aggregation devices market segment is categorized into clinical applications and research applications. The application segment is expected to dominate by clinical applications owing to increasing awareness among healthcare professionals about the benefits of platelet healthcare devices supplemented by the increasing incidences of the target diseases. In addition, increasing geriatric population globally is also expected to boost the demand of these devices in the clinical application within the forecast period.
An end-user segment of the platelet aggregation devices market includes the: standalone hospitals, research and academic institutes, diagnostic laboratories and other end users. In this segment, standalone hospitals are expected to capture the largest market share of the global platelet aggregation devices market in coming five years owing to the benefits offered by hospitals in conducting the platelet aggregation testing procedure, large patient population base for diseases such as bleeding disorders, cardiovascular diseases, and arthritis.
North America accounted for largest share of this market in 2016 and is expected to witness the fastest growth in global platelet aggregation devices market in coming five years. U.S. had the largest market share in platelet aggregation devices market in this region. The North American region has become the attractive destination for platelet aggregation products manufacturing companies due to the large patient population for target diseases; a significant number of patients undergoing cardiovascular surgeries and increasing prevalence of urological and bleeding disorders.
Europe is expected to attribute for the second largest position in this market within the forecast period due to the presence of leading manufacturers of platelet aggregation devices in this region coupled with increasing rate of clinical research Furthermore, especially in Italy, a large number of people suffering from cardiovascular disease, neoplasm, and strokes are also expected to fuel the demand for platelet aggregation devices in this region in coming five years. Asia Pacific is expected to be one of the attractive markets for platelet aggregation devices within the forecast period owing to the increasing incidences of mosquito-borne diseases such as malaria and dengue.
Latin America is expected to show an above average growth due to increasing awareness among healthcare professionals related to the benefits of platelet aggregation testing in various diseases diagnosis. In the Middle East and South Africa, market growth for platelet aggregation devices is expected to boost by improving political stability and increasing awareness related to platelet disorders.
Some of the key players of green building market such as Siemens AG, Helena Laboratories Corporation, Haemonetics Corporation, Accriva Diagnostics, F. Hoffman-La Roche Ltd, Helena Laboratories Corporation, Sysmex Corporation, Aggredyne, Inc., TEM Group, Sentinel Ch. S.P.A. among others.
Zion Market Research
4283, Express Lane,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Visit Our Blog: https://zionmarketresearch.wordpress.com/
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.